---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-22-026440"
form_type: "8-K"
ticker: "INVA"
cik: "0001080014"
company_name: "Innoviva, Inc."
filed_at: "2022-07-20T23:59:59+00:00"
generated_at: "2026-06-24T10:55:03.116841+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Innoviva closes sale of 750 Class A and 750 Class C units of Theravance Respiratory to Royalty Pharma

## Summary
- Closed sale of 750 Class A and 750 Class C units of Theravance Respiratory Company, LLC to Royalty Pharma Investments 2019 ICAV.
- Closing date was July 20, 2022, as previously announced on July 13, 2022.
- The seller was Innoviva, Inc. and its wholly-owned subsidiary Innoviva TRC Holdings LLC.

## SEC filing metadata
- accession: 0001140361-22-026440
- form_type: 8-K
- ticker: INVA
- cik: 0001080014
- company_name: Innoviva, Inc.
- filed_at: 2022-07-20T23:59:59+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1080014/000114036122026440/0001140361-22-026440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1080014/000114036122026440/ny20004764x2_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-22-026440
- JSON: https://secwatch.observer/filing/0001140361-22-026440.json
- Plain text: https://secwatch.observer/filing/0001140361-22-026440.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.